Position in VRTX
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$3,215,830
+$462,465 QoQ
Shares Held
6,474
+5.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#566
of 1,745 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $19,777,074 across 42 Biotechnology names. VRTX ranks #2 (16.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
5,514 | $3,438,199 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
6,474 | $3,215,830 | |
| 3 | INCY |
Incyte Corp
|
7,759 | $879,560 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,770 | $833,853 | |
| 5 | ARGX |
Argenx SE
|
809 | $750,565 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
3,045 | $733,753 | |
| 7 | TWST |
Twist Bioscience Corp
|
6,969 | $716,970 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
27,134 | $686,490 |
All Filings in VRTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,215,830 | 6,474 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,753,365 | 6,166 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,177,146 | 7,008 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,292,660 | 5,854 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,828,355 | 6,353 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,099,454 | 6,393 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $2,453,248 | 6,092 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $2,761,645 | 5,938 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,037,994 | 4,348 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $204,824 | 490 | Shares | Sole | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||